Sort by
Refine Your Search
-
services research. Duties and Responsibilities Successful candidates are expected to develop and lead an independent research program and participate in institutional efforts to translate novel imaging
-
as #1 in Ohio. Additionally, our residency program is ranked 24th through Doximity Residency Navigator. Duties and Responsibilities Faculty responsibilities are consistent with our tripartite mission
-
screening for biomarker discovery and functional genomics, or big data and machine learning methods. The Division of Neurogenetics is implementing a comprehensive program that integrates clinical
-
for biomarker discovery and functional genomics, or big data and machine learning methods. The Division of Neurogenetics is implementing a comprehensive program that integrates clinical neuropathological data
-
, 100% FTE position with an initial appointment of one year, with the potential for renewal based on performance, enrollment, and program needs. The role requires a commitment to innovative teaching
-
. The individuals selected for these positions will have ample opportunities to contribute to training, research, and other scholarly pursuits. Other duties include but are not limited to representing the program or
-
Inflammation Program (Open Rank/Track Faculty) Department: The Ohio State University College of Medicine and the Wexner Medical Center seek an academic cardiologist with clinical or translational research
-
therapeutic management., with an emphasis on leading a cutting-edge research program that complements existing departmental activities. Successful candidates will have already established a highly competitive
-
Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract Consistently ranked as one
-
Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract